12月8日至12月14日期间，百奥赛图(北京)医药科技股份有限公司挂牌上市。 | 上市日期 上市企业 | 所属板块 股票代码 | | --- | --- | | 12 月 10 日 百奥赛图(北京)医药科技股份有限公司 | 科创板 688796 | 百奥赛图(北京)医药科技股份有限公司(股票简称：百奥赛图;股票代码：688796)是一家创新技术驱动新 药研发的国际性生物技术公司,致力于成为全球新药发源地。基于底层基因编辑技术,百奥赛图自主研发 了RenMice(RenMab、RenLite、RenNano、RenTCR mimic)平台,用于全人治疗性单克隆抗体、双/多特异 性抗体、双抗ADC、纳米抗体和类TCR抗体的发现。百奥赛图正在对1000多个潜在可成药的靶点进行 规模化药物开发("千鼠万抗TM"计划),并已建立起超100万条全人抗体序列库,用于全球合作。 中国上市公司网/文 2025年12月8日-2025年12月14日期间IPO动态各个阶段速览： 一、IPO排队企业情况 截至12月14日，IPO排队企业266家，其中沪主板排队企业18家，科创板排队企业36家，深主板排队企 业20家，创业板排队企业28 ...

除了新增受理情况外，当周还有7家拟上市企业过会，其中3家已提交注册，还有4家处于过会状态。此 外，还有6家企业处于提交注册状态，所以当周共有9家企业的IPO申请提交注册。 处于过会状态的4家企业中，江苏原力数字科技股份有限公司被上市委提出了审议意见。上市委要求该 公司，评估实际控制人持股比例较低对发行人经营和控制权稳定性的影响，进一步明确巩固控制权的措 施和安排，并确保其有效性、充分性；进一步说明制作周期超过一年的项目收入确认时点的准确性和合 理性，分析并披露前述项目对发行人经营业绩可能产生的影响和风险。 2家终止审核的企业分别为创正电气股份有限公司（下称"创正电气"）、哈尔滨东盛金材科技（集团） 股份有限公司（下称"东盛金材"）。 12月8日～12月14日当周，沪深北交易所新增受理2单IPO申请，都来自科创板；4家处于过会状态，9家 已提交注册，2家注册生效，2家终止审核。 这2家新增受理的拟IPO企业分别为国仪量子技术（合肥）股份有限公司（下称"国仪量子"）、上海频准 激光科技股份有限公司（下称"频准激光"），分别拟融资11.69亿元、14.10亿元。 公开资料显示，国仪量子专注于高端科学仪器的研发，形成 ...

Core Viewpoint - Dongsheng Jin Cai Technology (Group) Co., Ltd. has announced the termination of its public offering of shares and the withdrawal of its listing application on the Beijing Stock Exchange due to ongoing inquiries and performance updates [1][2] Group 1: IPO and Regulatory Concerns - The company's IPO was accepted on December 30, 2024, but faced multiple delays and inquiries, with the latest round of inquiries still unanswered as of the announcement date [1] - Regulatory scrutiny has focused on the company's declining performance and the rationale behind its fundraising projects [2][7] - The bankruptcy restructuring of the company's largest supplier raised concerns about the stability of raw material supply [2][3] Group 2: Financial Performance - Dongsheng Jin Cai's main business involves the research, production, and sales of aluminum alloy element additives, with approximately 90% of revenue derived from this segment [3] - The company experienced significant revenue fluctuations, with reported revenues of 930 million yuan in 2021, 1.045 billion yuan in 2022, and a drop to 658 million yuan in 2023, marking a 37.05% year-on-year decline [4][9] - The net profit attributable to the parent company also saw a decline from 88.34 million yuan in 2021 to 41.39 million yuan in 2023, a decrease of 66.16% [4][9] Group 3: Supply Chain and Raw Material Dependency - The company has been heavily reliant on its largest supplier, Tianyuan Manganese Industry, which accounted for over 46% of its raw material purchases until its bankruptcy restructuring in September 2023 [3][4] - Despite the bankruptcy, the company claims it has alternative suppliers capable of meeting its raw material needs, thus mitigating supply risks [4][9] Group 4: Sales Model and Market Conditions - The company employs a long-term sales model, which has been criticized for potentially amplifying revenue volatility [7][8] - The decline in 2023 performance was attributed to a combination of factors, including a decrease in sales volume and rising costs, as well as a shift in customer behavior towards inventory reduction [9][10] Group 5: Future Outlook and Expansion Plans - Dongsheng Jin Cai plans to raise 350 million yuan for expansion projects, including the production of 60,000 tons of alloy additives and 30,000 tons of aluminum intermediate alloys [11][12] - The company aims to enhance its research capabilities with a new R&D center, although concerns remain regarding the feasibility of its expansion given current production capacity and market conditions [11][15] - The company anticipates a recovery in demand and profitability in 2024, with projected revenues of 745 million yuan and a net profit of 51 million yuan [9][10]

Core Viewpoint - Harbin Dongsheng Jin Cai Technology (Group) Co., Ltd. has suspended its IPO process due to financial report expiration, with concerns raised about its declining revenue and net profit during the reporting period [2][4][7]. Financial Performance - Dongsheng Jin Cai's revenue and net profit have shown a downward trend from 2021 to the first half of 2025, with revenue figures of 9.30 billion, 10.45 billion, 6.58 billion, 7.45 billion, and 3.67 billion, and net profits of 0.95 billion, 1.22 billion, 0.52 billion, 0.56 billion, and 0.20 billion respectively [4][7]. - The compound annual growth rates for revenue and net profit from 2021 to 2024 are -7.15% and -16.22% respectively [4][7]. Market Position - Despite a revenue peak of only 10.45 billion, Dongsheng Jin Cai holds the global market share leader position in aluminum alloy element additives, with a market share of 5.09% in 2024 [8][12]. - The company’s main product, aluminum alloy element additives, accounted for over 82% of its revenue during the reporting period, indicating high dependency on a single product [7][8]. Dividend and Financial Management - In 2022, Dongsheng Jin Cai distributed dividends totaling approximately 1.63 billion, which accounted for 71.06% of its net profit for the period from 2022 to 2024, nearing the regulatory threshold set by the Beijing Stock Exchange [2][12][14]. - The controlling shareholder's family received at least 1.13 billion from dividends, raising concerns about potential financial mismanagement [12][15]. Borrowing and Legal Issues - The company provided loans totaling nearly 70 million to various entities, with some borrowers defaulting, leading to legal disputes [12][15][16]. - The largest borrower, Tianyuan Manganese Industry Group, filed for bankruptcy reorganization, which could impact Dongsheng Jin Cai's financial stability [17]. Market Outlook - The global market for aluminum alloy element additives is projected to reach 11.696 billion in 2024, with domestic market size expected to be 6.966 billion [8][9]. - The company anticipates a gradual recovery in product sales and revenue as market conditions improve following inventory clearances and demand recovery [7][8].

Core Viewpoint - Dongsheng Jinmaterial's significant decline in operating performance in 2023 has drawn attention from the exchange, with a notable drop in both revenue and net profit reported in their latest financial disclosures [2][3][10]. Group 1: Financial Performance - In the first half of 2025, the company reported operating revenue of 367 million yuan, a year-on-year decrease of 0.35%, and a net profit attributable to shareholders of 2.021 million yuan, down 34.15% [13][15]. - The company's revenue from 2021 to the first half of 2025 shows a downward trend, with revenues of 9.30 billion yuan in 2021, 10.45 billion yuan in 2022, 6.58 billion yuan in 2023, and 3.68 billion yuan in the first half of 2025 [6][10]. - The net profit figures for the same period were 946.98 million yuan in 2021, 1.22 billion yuan in 2022, 517.59 million yuan in 2023, and 306.93 million yuan in the first half of 2025, indicating a significant decline in profitability [6][10]. Group 2: Business Operations - Dongsheng Jinmaterial specializes in the research, production, and sales of aluminum alloy element additives and other new metal functional materials, with approximately 90% of its revenue derived from aluminum alloy element additives [3][5]. - The company is one of the few globally capable of mass-producing aluminum alloy element additives with a metal content exceeding 95%, showcasing its technological leadership in the industry [3][5]. - The company faced inquiries regarding its performance fluctuations, low R&D investment, and supply chain risks, which were addressed in their responses to the exchange [5][10]. Group 3: R&D and Innovation - The company's R&D expenditure as a percentage of revenue was reported at 1.66% in 2023, which is lower than the 2%-5% range of comparable companies [16][20]. - Dongsheng Jinmaterial attributed its lower R&D spending to its unique industry characteristics and accounting practices, stating that costs related to trial products were not included in R&D expenses [20][21]. - The company plans to raise approximately 350 million yuan for projects including the production of alloy additives and the establishment of a research center [27][28].

Core Viewpoint - Dongsheng Jin Cai's listing process on the Beijing Stock Exchange has been updated, with significant issues highlighted in its financial performance and governance structure [1][3]. Financial Performance - Dongsheng Jin Cai's revenue from 2021 to the first half of 2024 shows a decline, with figures of 930 million, 1.045 billion, 658 million, and 368 million respectively. Net profits for the same period were 95 million, 122 million, 52 million, and 31 million [3]. - In 2023, the company's revenue and net profit decreased by 37.05% and 57.53% year-on-year, raising concerns about its sustainability [3][4]. - The company attributes its performance issues to external factors such as raw material price volatility and the impact of the pandemic on production stability [4]. Market Position and Competitiveness - Despite the performance decline, Dongsheng Jin Cai claims a turnaround in 2024, projecting a 13.17% increase in revenue and a 23.40% increase in net profit [4]. - However, in the same market conditions, its 2025 performance is below industry averages, with first-quarter revenue of 173 million and net profit of 11 million compared to industry averages of 3.319 billion and 53 million [4]. Profitability Metrics - Dongsheng Jin Cai maintains a higher gross margin compared to industry peers, with gross margins of 16.62%, 19.26%, 16.78%, and 17.58% from 2021 to the first half of 2024, significantly above the industry average [6]. - The company’s R&D expenditure is notably low, with rates of 0.70%, 1.27%, 1.66%, and 1.26% during the same period, far below the industry average of 3.53% to 9.93% [8]. Expansion Plans - The company plans to issue up to 17 million shares to raise 350 million for production expansion and R&D projects, aiming to double its production capacity [9][10]. - Despite low capacity utilization rates, which were 114.90%, 72%, and 67.98% from 2021 to 2023, the company is pursuing expansion, raising concerns about potential over-financing [10]. Ownership Structure - Dongsheng Jin Cai is a family-controlled enterprise, with the Zhang family holding 84.08% of the shares, leading to potential conflicts of interest in governance and financial decisions [11][12]. - The family has engaged in multiple share transfers and significant cash dividends, raising questions about the motivations behind these financial maneuvers [13][14].

Core Viewpoint - Harbin Dongsheng Jin Materials Technology (Group) Co., Ltd. is progressing with its IPO on the Beijing Stock Exchange, addressing inquiries regarding market space, operational performance decline risks, raw material supply stability, and corporate governance [1][5]. Company Overview - Established in 1995, Dongsheng Jin Materials specializes in the research, production, and sales of functional additives for aluminum alloy smelting [3]. - The company has a significant ownership structure, with the controlling shareholder, Zhang Shengtian, and his family holding over 80% of the shares [4][5]. Financial Performance - Dongsheng Jin Materials reported a notable decline in performance for 2023, with revenues of 658 million yuan, down 37.05% year-on-year, and a net profit of 30.69 million yuan, down 66.16% [7][8]. - The company distributed a total of 163 million yuan in cash dividends prior to its listing [2][3]. Supply Chain Concerns - The primary raw material, electrolytic manganese, is sourced from Tianyuan Manganese Industry, which filed for bankruptcy reorganization in September 2023. The company has been asked to clarify the impact of this on its supply stability [9][10]. - Despite the bankruptcy, Dongsheng Jin Materials indicated that the supply situation remains stable, with no significant adverse effects on procurement [10]. Governance and Control - The North Exchange has raised questions regarding the capability of the actual controllers to manage the company's operational intensity and the long-term arrangements for maintaining control [5].